Traditional Chinese Medicine Targeting Heat Shock Proteins as Therapeutic Strategy for Heart Failure

Yanchun Wang1, Junxuan Wu2, Dawei Wang2

  • 1Shenyang the Tenth People's Hospital, Shenyang, China.

Frontiers in Pharmacology
|February 4, 2022
PubMed

Insights

Heat shock proteins (HSPs) protect the heart during heart failure (HF). Traditional Chinese Medicine (TCM) regulates HSPs, offering potential new therapeutic strategies for HF treatment and mechanism studies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Heart failure (HF) is a critical stage of heart disease, leading to significant mortality and hospitalizations.
  • HF pathogenesis involves cardiac hypertrophy, remodeling, fibrosis, cell death, inflammation, and oxidative stress.
  • Heat shock proteins (HSPs) play a crucial role in maintaining cellular protein stability and protecting the heart from stress-induced damage.

Purpose of the Study:

  • To review the multifaceted functions of HSPs in the context of heart failure.
  • To explore the therapeutic potential of Traditional Chinese Medicine (TCM) in modulating HSP expression for HF.
  • To provide insights into novel mechanisms and treatments for HF through the lens of TCM-HSP interactions.

Main Methods:

  • Literature review focusing on the role of HSPs in heart failure pathophysiology.
  • Analysis of studies investigating Traditional Chinese Medicine's effects on HSPs.
  • Synthesis of current knowledge on HSP regulation by TCM in HF models.

Main Results:

  • HSPs are vital for protein homeostasis and cellular protection against cardiac dysfunction and apoptosis in HF.
  • TCM interventions have demonstrated the ability to regulate HSP expression.
  • TCM's modulation of HSPs shows promise for ameliorating HF progression.

Conclusions:

  • HSPs are key players in protecting the heart against HF.
  • TCM offers a promising avenue for therapeutic intervention in HF by regulating HSPs.
  • Further research into TCM-HSP interactions can unlock new strategies for HF treatment.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
550
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
39
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
47
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
28
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
782
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
91